Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1001 entries
Sorted by: Best Match Show Resources per page
Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population

veteran

Joyce V, Bendavid E.
GSID: HWWBaPtwAj0J
M Desai, V Joyce, E Bendavid… - Clinical Infectious …, 2015 - academic.oup.com

Background. To characterize the association of antiretroviral drug combinations on risk of cardiovascular events. Methods. Certain antiretroviral medications for human …

Cite
Desai, M., Joyce, V., Bendavid, E., Olshen, R. A., Hlatky, M., Chow, A., ... & Owens, D. K. (2015). Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population. Clinical Infectious Diseases, 61(3), 445-452.
Desai, Manisha, et al. "Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population." Clinical Infectious Diseases 61.3 (2015): 445-452.
Copy Download .nbib Format: MLA
[Injurious drug combinations, "drug interaction"].

Ugeskrift for laeger

Andersen AH, Pedersen A.
PMID: 5333678
Ugeskr Laeger. 1966 Aug 18;128(33):943-8.

No abstract available.

Cite
Andersen AH, Pedersen A. Uheldige laegemiddelkombinationer "drug interaction". [Injurious drug combinations, "drug interaction"]. Ugeskr Laeger. 1966;128(33):943-8
Andersen, A. H., & Pedersen, A. (1966). Uheldige laegemiddelkombinationer "drug interaction". [Injurious drug combinations, "drug interaction"]. Ugeskrift for laeger, 128(33), 943-8.
Andersen, A H, and Pedersen, A. "Uheldige laegemiddelkombinationer "drug interaction"." [Injurious drug combinations, "drug interaction"]. Ugeskrift for laeger vol. 128,33 (1966): 943-8.
Andersen AH, Pedersen A. Uheldige laegemiddelkombinationer "drug interaction". [Injurious drug combinations, "drug interaction"]. Ugeskr Laeger. 1966 Aug 18;128(33):943-8. Danish. PMID: 5333678.
Copy Download .nbib Format: NLM
A brief history of antiretroviral therapy of HIV infection: success and challenges.

Annali dell'Istituto superiore di sanita

Palmisano L, Vella S.
PMID: 21430338
Ann Ist Super Sanita. 2011;47(1):44-8. doi: 10.4415/ANN_11_01_10.

Unprecedented efforts in the fields of biology, pharmacology and clinical care have contributed to progressively turn HIV infection from an inevitably fatal condition into a chronic manageable disease, at least in the countries where HIV infected people have full...

Cite
Palmisano L, Vella S. A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita. 2011;47(1):44-8doi: 10.4415/ANN_11_01_10.
Palmisano, L., & Vella, S. (2011). A brief history of antiretroviral therapy of HIV infection: success and challenges. Annali dell'Istituto superiore di sanita, 47(1), 44-8. https://doi.org/10.4415/ANN_11_01_10
Palmisano, Lucia, and Vella, Stefano. "A brief history of antiretroviral therapy of HIV infection: success and challenges." Annali dell'Istituto superiore di sanita vol. 47,1 (2011): 44-8. doi: https://doi.org/10.4415/ANN_11_01_10
Palmisano L, Vella S. A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita. 2011;47(1):44-8. doi: 10.4415/ANN_11_01_10. PMID: 21430338.
Copy Download .nbib Format: NLM
What is synergy? The Saariselkä agreement revisited.

Frontiers in pharmacology

Tang J, Wennerberg K, Aittokallio T.
PMID: 26388771
Front Pharmacol. 2015 Sep 01;6:181. doi: 10.3389/fphar.2015.00181. eCollection 2015.

Many biological or chemical agents when combined interact with each other and produce a synergistic response that cannot be predicted based on the single agent responses alone. However, depending on the postulated null hypothesis of non-interaction, one may end...

Cite
Tang J, Wennerberg K, Aittokallio T. What is synergy? The Saariselkä agreement revisited. Front Pharmacol. 2015;6:181doi: 10.3389/fphar.2015.00181.
Tang, J., Wennerberg, K., & Aittokallio, T. (2015). What is synergy? The Saariselkä agreement revisited. Frontiers in pharmacology, 6181. https://doi.org/10.3389/fphar.2015.00181
Tang, Jing, et al. "What is synergy? The Saariselkä agreement revisited." Frontiers in pharmacology vol. 6 (2015): 181. doi: https://doi.org/10.3389/fphar.2015.00181
Tang J, Wennerberg K, Aittokallio T. What is synergy? The Saariselkä agreement revisited. Front Pharmacol. 2015 Sep 01;6:181. doi: 10.3389/fphar.2015.00181. eCollection 2015. PMID: 26388771; PMCID: PMC4555011.
Copy Download .nbib Format: NLM
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library.

Frontiers in microbiology

Feng J, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y.
PMID: 27242757
Front Microbiol. 2016 May 23;7:743. doi: 10.3389/fmicb.2016.00743. eCollection 2016.

Although currently recommended antibiotics for Lyme disease such as doxycycline or amoxicillin cure the majority of the patients, about 10-20% of patients treated for Lyme disease may experience lingering symptoms including fatigue, pain, or joint and muscle aches. Under...

Cite
Feng J, Shi W, Zhang S, et al. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Front Microbiol. 2016;7:743doi: 10.3389/fmicb.2016.00743.
Feng, J., Shi, W., Zhang, S., Sullivan, D., Auwaerter, P. G., & Zhang, Y. (2016). A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Frontiers in microbiology, 7743. https://doi.org/10.3389/fmicb.2016.00743
Feng, Jie, et al. "A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library." Frontiers in microbiology vol. 7 (2016): 743. doi: https://doi.org/10.3389/fmicb.2016.00743
Feng J, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Front Microbiol. 2016 May 23;7:743. doi: 10.3389/fmicb.2016.00743. eCollection 2016. PMID: 27242757; PMCID: PMC4876775.
Copy Download .nbib Format: NLM
Genotoxic Damage to Glioblastoma Cells Treated with 6 MV X-Radiation in The Presence or Absence of Methoxy Estradiol, IUDR or Topotecan.

Cell journal

Eyvazzadeh N, Neshasteh-Riz A, Mahdavi SR, Mohsenifar A.
PMID: 26199910
Cell J. 2015;17(2):312-21. doi: 10.22074/cellj.2016.3738. Epub 2015 Jul 11.

OBJECTIVE: To explore the cumulative genotoxic damage to glioblastoma (GBM) cells, grown as multicellular spheroids, following exposure to 6 MV X-rays (2 Gy, 22 Gy) with or without, 2- methoxy estradiol (2ME2), iododeoxyuridine (IUDR) or topotecan (TPT), using the...

Cite
Eyvazzadeh N, Neshasteh-Riz A, Mahdavi SR, et al. Genotoxic Damage to Glioblastoma Cells Treated with 6 MV X-Radiation in The Presence or Absence of Methoxy Estradiol, IUDR or Topotecan. Cell J. 2015;17(2):312-21doi: 10.22074/cellj.2016.3738.
Eyvazzadeh, N., Neshasteh-Riz, A., Mahdavi, S. R., & Mohsenifar, A. (2015). Genotoxic Damage to Glioblastoma Cells Treated with 6 MV X-Radiation in The Presence or Absence of Methoxy Estradiol, IUDR or Topotecan. Cell journal, 17(2), 312-21. https://doi.org/10.22074/cellj.2016.3738
Eyvazzadeh, Nazila, et al. "Genotoxic Damage to Glioblastoma Cells Treated with 6 MV X-Radiation in The Presence or Absence of Methoxy Estradiol, IUDR or Topotecan." Cell journal vol. 17,2 (2015): 312-21. doi: https://doi.org/10.22074/cellj.2016.3738
Eyvazzadeh N, Neshasteh-Riz A, Mahdavi SR, Mohsenifar A. Genotoxic Damage to Glioblastoma Cells Treated with 6 MV X-Radiation in The Presence or Absence of Methoxy Estradiol, IUDR or Topotecan. Cell J. 2015;17(2):312-21. doi: 10.22074/cellj.2016.3738. Epub 2015 Jul 11. PMID: 26199910; PMCID: PMC4503845.
Copy Download .nbib Format: NLM
Targeted drug combinations: avant-garde oncology.

Annals of translational medicine

Dan TD, Palmer JD.
PMID: 26244146
Ann Transl Med. 2015 Jul;3(11):159. doi: 10.3978/j.issn.2305-5839.2015.06.17.

No abstract available.

Cite
Dan TD, Palmer JD. Targeted drug combinations: avant-garde oncology. Ann Transl Med. 2015;3(11):159doi: 10.3978/j.issn.2305-5839.2015.06.17.
Dan, T. D., & Palmer, J. D. (2015). Targeted drug combinations: avant-garde oncology. Annals of translational medicine, 3(11), 159. https://doi.org/10.3978/j.issn.2305-5839.2015.06.17
Dan, Tu D, and Palmer, Joshua D. "Targeted drug combinations: avant-garde oncology." Annals of translational medicine vol. 3,11 (2015): 159. doi: https://doi.org/10.3978/j.issn.2305-5839.2015.06.17
Dan TD, Palmer JD. Targeted drug combinations: avant-garde oncology. Ann Transl Med. 2015 Jul;3(11):159. doi: 10.3978/j.issn.2305-5839.2015.06.17. PMID: 26244146; PMCID: PMC4499666.
Copy Download .nbib Format: NLM
Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter.

JMIR public health and surveillance

Adrover C, Bodnar T, Huang Z, Telenti A, Salathé M.
PMID: 27227141
JMIR Public Health Surveill. 2015 Jul 27;1(2):e7. doi: 10.2196/publichealth.4488. eCollection 2015.

BACKGROUND: Social media platforms are increasingly seen as a source of data on a wide range of health issues. Twitter is of particular interest for public health surveillance because of its public nature. However, the very public nature of...

Cite
Adrover C, Bodnar T, Huang Z, et al. Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter. JMIR Public Health Surveill. 2015;1(2):e7doi: 10.2196/publichealth.4488.
Adrover, C., Bodnar, T., Huang, Z., Telenti, A., & Salathé, M. (2015). Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter. JMIR public health and surveillance, 1(2), e7. https://doi.org/10.2196/publichealth.4488
Adrover, Cosme, et al. "Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter." JMIR public health and surveillance vol. 1,2 (2015): e7. doi: https://doi.org/10.2196/publichealth.4488
Adrover C, Bodnar T, Huang Z, Telenti A, Salathé M. Identifying Adverse Effects of HIV Drug Treatment and Associated Sentiments Using Twitter. JMIR Public Health Surveill. 2015 Jul 27;1(2):e7. doi: 10.2196/publichealth.4488. eCollection 2015. PMID: 27227141; PMCID: PMC4869211.
Copy Download .nbib Format: NLM
REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER.

Current colorectal cancer reports

Sreevalsan S, Safe S.
PMID: 25584043
Curr Colorectal Cancer Rep. 2013 Dec;9(4):350-357. doi: 10.1007/s11888-013-0190-5.

Several agents used for treatment of colon and other cancers induce reactive oxygen species (ROS) and this plays an important role in their anticancer activities. In addition to the well-known proapoptotic effects of ROS inducers, these compounds also decrease...

Cite
Sreevalsan S, Safe S. REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER. Curr Colorectal Cancer Rep. 2013;9(4):350-357doi: 10.1007/s11888-013-0190-5.
Sreevalsan, S., & Safe, S. (2013). REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER. Current colorectal cancer reports, 9(4), 350-357. https://doi.org/10.1007/s11888-013-0190-5
Sreevalsan, Sandeep, and Safe, Stephen. "REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER." Current colorectal cancer reports vol. 9,4 (2013): 350-357. doi: https://doi.org/10.1007/s11888-013-0190-5
Sreevalsan S, Safe S. REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER. Curr Colorectal Cancer Rep. 2013 Dec;9(4):350-357. doi: 10.1007/s11888-013-0190-5. PMID: 25584043; PMCID: PMC4288935.
Copy Download .nbib Format: NLM
Pattern of CD4 T-lymphocyte Values in Cancer Patients on Cytotoxic Therapy.

Annals of medical and health sciences research

Madu A, Ocheni S, Ibegbulam O, Aguwa E, Madu K.
PMID: 24379998
Ann Med Health Sci Res. 2013 Oct;3(4):498-503. doi: 10.4103/2141-9248.122054.

BACKGROUND: Assessment of patients prior to cytotoxic chemotherapy usually includes absolute neutrophils count. Other cellular markers of susceptibility to infection as well as immunocompetence include the T Helper lymphocyte count. In cancer patients, decrease in these lymphocytes has been...

Cite
Madu A, Ocheni S, Ibegbulam O, et al. Pattern of CD4 T-lymphocyte Values in Cancer Patients on Cytotoxic Therapy. Ann Med Health Sci Res. 2013;3(4):498-503doi: 10.4103/2141-9248.122054.
Madu, A., Ocheni, S., Ibegbulam, O., Aguwa, E., & Madu, K. (2013). Pattern of CD4 T-lymphocyte Values in Cancer Patients on Cytotoxic Therapy. Annals of medical and health sciences research, 3(4), 498-503. https://doi.org/10.4103/2141-9248.122054
Madu, Aj, et al. "Pattern of CD4 T-lymphocyte Values in Cancer Patients on Cytotoxic Therapy." Annals of medical and health sciences research vol. 3,4 (2013): 498-503. doi: https://doi.org/10.4103/2141-9248.122054
Madu A, Ocheni S, Ibegbulam O, Aguwa E, Madu K. Pattern of CD4 T-lymphocyte Values in Cancer Patients on Cytotoxic Therapy. Ann Med Health Sci Res. 2013 Oct;3(4):498-503. doi: 10.4103/2141-9248.122054. PMID: 24379998; PMCID: PMC3868113.
Copy Download .nbib Format: NLM
The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.

Frontiers in endocrinology

Bowers LW, Rossi EL, O'Flanagan CH, deGraffenried LA, Hursting SD.
PMID: 26029167
Front Endocrinol (Lausanne). 2015 May 15;6:77. doi: 10.3389/fendo.2015.00077. eCollection 2015.

Numerous epidemiological and pre-clinical studies have demonstrated that the insulin/insulin-like growth factor (IGF) system plays a key role in the development and progression of several types of cancer. Insulin/IGF signaling, in cooperation with chronic low-grade inflammation, is also an...

Cite
Bowers LW, Rossi EL, O'Flanagan CH, et al. The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Front Endocrinol (Lausanne). 2015;6:77doi: 10.3389/fendo.2015.00077.
Bowers, L. W., Rossi, E. L., O'Flanagan, C. H., deGraffenried, L. A., & Hursting, S. D. (2015). The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Frontiers in endocrinology, 677. https://doi.org/10.3389/fendo.2015.00077
Bowers, Laura W, et al. "The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link." Frontiers in endocrinology vol. 6 (2015): 77. doi: https://doi.org/10.3389/fendo.2015.00077
Bowers LW, Rossi EL, O'Flanagan CH, deGraffenried LA, Hursting SD. The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link. Front Endocrinol (Lausanne). 2015 May 15;6:77. doi: 10.3389/fendo.2015.00077. eCollection 2015. PMID: 26029167; PMCID: PMC4432799.
Copy Download .nbib Format: NLM
Fitness Trade-Offs Associated with the Evolution of Resistance to Antifungal Drug Combinations.

Cell reports

Hill JA, O'Meara TR, Cowen LE.
PMID: 25660029
Cell Rep. 2015 Feb 10;10(5):809-819. doi: 10.1016/j.celrep.2015.01.009. Epub 2015 Feb 05.

The evolution of drug resistance threatens human health worldwide. An emerging strategy to mitigate drug resistance is combination therapy. The fate of multidrug-resistant pathogens depends on their fitness relative to susceptible counterparts, yet the fitness consequences of multidrug resistance...

Cite
Hill JA, O'Meara TR, Cowen LE. Fitness Trade-Offs Associated with the Evolution of Resistance to Antifungal Drug Combinations. Cell Rep. 2015;10(5):809-819doi: 10.1016/j.celrep.2015.01.009.
Hill, J. A., O'Meara, T. R., & Cowen, L. E. (2015). Fitness Trade-Offs Associated with the Evolution of Resistance to Antifungal Drug Combinations. Cell reports, 10(5), 809-819. https://doi.org/10.1016/j.celrep.2015.01.009
Hill, Jessica A, et al. "Fitness Trade-Offs Associated with the Evolution of Resistance to Antifungal Drug Combinations." Cell reports vol. 10,5 (2015): 809-819. doi: https://doi.org/10.1016/j.celrep.2015.01.009
Hill JA, O'Meara TR, Cowen LE. Fitness Trade-Offs Associated with the Evolution of Resistance to Antifungal Drug Combinations. Cell Rep. 2015 Feb 10;10(5):809-819. doi: 10.1016/j.celrep.2015.01.009. Epub 2015 Feb 05. PMID: 25660029.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1001 entries